Quantification of ventricular repolarization heterogeneity during moxifloxacin or sotalol administration using -index. (April 2015)
- Record Type:
- Journal Article
- Title:
- Quantification of ventricular repolarization heterogeneity during moxifloxacin or sotalol administration using -index. (April 2015)
- Main Title:
- Quantification of ventricular repolarization heterogeneity during moxifloxacin or sotalol administration using -index
- Authors:
- Rivolta, M W
Mainardi, L T
Sassi, R - Abstract:
- <abstract> <title>Abstract</title> <p>Drug-induced alterations of ventricular heterogeneity must be limited to avoid induction of lethal ventricular arrhythmias. In here, a new parameter called <inline-formula><tex-math><?CDATA $\mathcal{V}$ ?></tex-math><?MML <mml:math><mml:mi mathvariant='script'>V</mml:mi></mml:math> ?><inline-graphic xlink:href="ark:/27927/pgj2cb2tnvq" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></inline-formula>-index, able to measure the standard deviation of myocites' repolarization times, was evaluated after moxifloxacin and sotalol administration. The two drugs are known to provide different alteration of the QT interval length ranging from subtle (moxifloxacin) to evident (sotalol). In fact, while the former is employed as active-comparator in thorough QT studies, the latter might induce torsades de pointes. 24 h Holter ECGs of 39 (sotalol) and 68 (moxifloxacin) healthy subjects were retrospectively analyzed. The recordings were performed after infusion of the drugs and after the placebo (moxifloxacin) or at baseline (sotalol). The corrected QT interval (QT<sub><italic>c</italic></sub>) was included as well in the study, for a direct comparison. In both populations, <inline-formula><tex-math><?CDATA $\mathcal{V}$ ?></tex-math><?MML <mml:math><mml:mi mathvariant='script'>V</mml:mi></mml:math> ?><inline-graphic xlink:href="ark:/27927/pgj2cb2tnmv" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink"<abstract> <title>Abstract</title> <p>Drug-induced alterations of ventricular heterogeneity must be limited to avoid induction of lethal ventricular arrhythmias. In here, a new parameter called <inline-formula><tex-math><?CDATA $\mathcal{V}$ ?></tex-math><?MML <mml:math><mml:mi mathvariant='script'>V</mml:mi></mml:math> ?><inline-graphic xlink:href="ark:/27927/pgj2cb2tnvq" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></inline-formula>-index, able to measure the standard deviation of myocites' repolarization times, was evaluated after moxifloxacin and sotalol administration. The two drugs are known to provide different alteration of the QT interval length ranging from subtle (moxifloxacin) to evident (sotalol). In fact, while the former is employed as active-comparator in thorough QT studies, the latter might induce torsades de pointes. 24 h Holter ECGs of 39 (sotalol) and 68 (moxifloxacin) healthy subjects were retrospectively analyzed. The recordings were performed after infusion of the drugs and after the placebo (moxifloxacin) or at baseline (sotalol). The corrected QT interval (QT<sub><italic>c</italic></sub>) was included as well in the study, for a direct comparison. In both populations, <inline-formula><tex-math><?CDATA $\mathcal{V}$ ?></tex-math><?MML <mml:math><mml:mi mathvariant='script'>V</mml:mi></mml:math> ?><inline-graphic xlink:href="ark:/27927/pgj2cb2tnmv" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></inline-formula>-index and QT<sub><italic>c</italic></sub> increased along with the drugs' serum concentration and were statistically different from values in the placebo arm or at baseline (<italic>p</italic> &lt; 0.05).</p> <p>With sotalol, the maximum value of <inline-formula><tex-math><?CDATA $\mathcal{V}$ ?></tex-math><?MML <mml:math><mml:mi mathvariant='script'>V</mml:mi></mml:math> ?><inline-graphic xlink:href="ark:/27927/pgj2cb2tp56" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></inline-formula>-index occurred, on average, after 5.64 h from the infusion, whereas for QT<sub><italic>c</italic></sub> after about 4.27 h. The two metrics displayed evident changes (<inline-formula><tex-math><?CDATA $\mathcal{V}$ ?></tex-math><?MML <mml:math><mml:mrow><mml:mi mathvariant='script'>V</mml:mi></mml:mrow></mml:math> ?><inline-graphic xlink:href="ark:/27927/pgj2cb2tp33" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></inline-formula>-index: 27.79 ms ± 4.89 ms versus 60.13 ms ± 18.52 ms; QT corrected: 387.07 ms ± 19.84 ms versus 437.76 ± 32.05 ms; <italic>p</italic> &lt; 0.05). Regarding moxifloxacin, maximum values were reached, on average, 5.01 h after administration for <inline-formula><tex-math><?CDATA $\mathcal{V}$ ?></tex-math><?MML <mml:math><mml:mi mathvariant='script'>V</mml:mi></mml:math> ?><inline-graphic xlink:href="ark:/27927/pgj2cb2tn3k" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></inline-formula>-index (30.70 ms ± 8.32 ms versus 40.48 ms ± 7.61 ms; <italic>p</italic> &lt; 0.05), and 4.37 h for QT<sub><italic>c</italic></sub> (404.29 ms ± 29.05 ms versus 426.77 ± 36.67 ms; <italic>p</italic> &lt; 0.05). They were statistically different from baseline values. With both drugs, the maximal percent variation after administration was higher for <inline-formula><tex-math><?CDATA $\mathcal{V}$ ?></tex-math><?MML <mml:math><mml:mi mathvariant='script'>V</mml:mi></mml:math> ?><inline-graphic xlink:href="ark:/27927/pgj2cb2tp9d" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></inline-formula>-index than QT<sub><italic>c</italic></sub> (moxifloxacin: 34.56% ± 24.60% versus 5.56% ± 2.98% ; sotalol: 114.77% ± 33.15% versus 12.13% ± 2.85% ; <italic>p</italic> &lt; 0.05).</p> <p>The study suggests that the standard deviation of the ventricular repolarization times, as quantified by the <inline-formula><tex-math><?CDATA $\mathcal{V}$ ?></tex-math><?MML <mml:math><mml:mi mathvariant='script'>V</mml:mi></mml:math> ?><inline-graphic xlink:href="ark:/27927/pgj2cb2tngn" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></inline-formula>-index, might be an effective measure of spatial heterogeneity.</p> </abstract> … (more)
- Is Part Of:
- Physiological measurement. Volume 36:Number 4(2015:Apr.)
- Journal:
- Physiological measurement
- Issue:
- Volume 36:Number 4(2015:Apr.)
- Issue Display:
- Volume 36, Issue 4 (2015)
- Year:
- 2015
- Volume:
- 36
- Issue:
- 4
- Issue Sort Value:
- 2015-0036-0004-0000
- Page Start:
- 803
- Page End:
- 811
- Publication Date:
- 2015-04
- Subjects:
- Physiology -- Measurement -- Periodicals
Patient monitoring -- Periodicals
612 - Journal URLs:
- http://ioppublishing.org/ ↗
http://iopscience.iop.org/0967-3334 ↗ - DOI:
- 10.1088/0967-3334/36/4/803 ↗
- Languages:
- English
- ISSNs:
- 0967-3334
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3849.xml